Pulse mistake costs Astellas
March 15, 2013Medical Communications, Sales and Marketing ABPI, Astellas, PMCPA, pulse
A mistake by medical journal Pulse has landed Astellas Pharma in hot water with the PMCPA, enforcers of the ABPI …
Merck makes Alzheimer’s deal
March 14, 2013Research and Development, Sales and Marketing Alzheimer's, Merck
Merck is teaming up with Texas-based Luminex Corporation to develop a companion diagnostic to help in its dementia programme. The …
J&J opens London hub
March 14, 2013Medical Communications, Research and Development, Sales and Marketing J&J, JJ, London, research
Johnson & Johnson has opened the doors to a new life sciences centre in London that forms part of a …
MHRA wins data scam case
March 13, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aptuit, MHRA, data
An ex-employee of research organisation Aptuit has been found guilty of changing pre-clinical trial data as part of a bid to …
AbbVie guards Humira data
March 13, 2013Sales and Marketing AbbVie, Abbott, Humira, RA, transparency
AbbVie has issued two injunctions against the European Medicines Agency to prevent the regulator revealing data about rheumatoid arthritis drug …
Roche chairman standing down
March 13, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, humer
The chairman of the Board of directors at Roche, Franz Humer, has announced that he will not stand for re-election …
A clinically-led NHS: a new opportunity to improve health
March 13, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CCG, NHS, Portmsouth, hogan, pharmafile
Dr Jim Hogan was speaking at the Prescriber and Pharmafocus conference: CCGs, the new NHS and Pharma in December.First of …
Janssen submits diabetes combination
March 12, 2013Sales and Marketing Janssen, diabetes
Janssen has submitted a combination of its investigational diabetes drug canagliflozin with immediate-release metformin to the European Medicines Agency.The manufacturer, …
Roche bins Galapagos tie-up
March 12, 2013Sales and Marketing COPD, Galapagos, Roche
Roche has ended its three-year old alliance with Belgian drug discovery specialist Galapagos because of a ‘strategic change’. The companies …
NHS Commissioning Board sets out interim arrangements
March 12, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hakin, NHS
The NHS Commissioning Board has announced interim arrangements for the post of chief operating officer and deputy chief executive. Later …
Impax hit by FDA re-inspection failure
March 11, 2013Manufacturing and Production Impax, hayward
Impax Laboratories has been hit by the news that another (FDA inspection of its troubled manufacturing facility in Hayward, California, …
New AF possibility for Xarelto
March 11, 2013Sales and Marketing Bayer, FDA, Xarelto
Bayer HealthCare is to launch a new trial of its oral blood thinner Xarelto just days after the FDA knocked …
Hospitals not ‘coasting’, Hunt told
March 11, 2013Sales and Marketing Hunt, NHS
Health secretary Jeremy Hunt has angered NHS groups with a speech in which he said some hospitals were ‘coasting’ and …
Merck to close Irish manufacturing unit
March 11, 2013Manufacturing and Production MSD, Merck
Merck & Co has said that a manufacturing unit in Rathdrum, Ireland will close by the end of 2015 with …
Ajinomoto expands in bio with Althea acquisition
March 11, 2013Manufacturing and Production Ajinomoto, althea
Japanese drugmaker Ajinomoto has agreed to acquire Althea Technologies, a provider of biopharmaceutical development and manufacturing services, for an estimated …
Contract research news in brief
March 11, 2013Research and Development Accelovance, BioLamina, Clinstar LLC, Critical Path Services, PRA, PSI CRO, Radiant Development, Roche, Synta
Consolidation news in the CRO sector as Accelovance buys Radiant and PRA snaps up Clinstar, plus updates from Roche/BioLamina, PSI …
Pharma manufacturing news in brief
March 11, 2013Business Services, Manufacturing and Production Actavis, DSM, Eisai, J&J, JJ, Marken, SAFC, Sagent Pharma
Actavis revises supply deal with Sagent, facility updates from Marken and SAFC, a supply deal for DSM plus another J&J …
Growth for Merck KGaA
March 8, 2013Research and Development
2012 saw German firm’s pharma division helping drive strong sales. Pharma revenue helped drive growth at Merck KGaA last year, with …
GSK files albiglutide in EU
March 8, 2013Research and Development
GlaxoSmithKline has filed its investigational, long-acting diabetes drug albiglutide with the European Medicines Agency.The GLP-1 receptor agonist, which will take …
ABPI supply chain warning
March 7, 2013Manufacturing and Production, Sales and Marketing ABPI, API, EFPIA
The ABPI is warning of supply chain problems which may cause a bottleneck in UK pharma manufacture this summer. The …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
